Hayashi Daichi, Gould Elaine, Shroyer Robert, van Staalduinen Eric, Yang Jie, Mufti Musa, Huang Mingqian
Department of Radiology, State University of New York at Stony Brook, Stony Brook, NY 11794, United States.
Department of Family, Population and Preventive Medicine, Stony Brook Medicine, Stony Brook, NY 11794, United States.
World J Radiol. 2021 Oct 28;13(10):344-353. doi: 10.4329/wjr.v13.i10.344.
Adhesive capsulitis is a relatively common condition that can develop in cancer patients during treatment. Positron emission tomography - computed tomography (PET-CT) is routinely performed as a follow-up study in cancer patients after therapy. Being aware of PET-CT findings to suggest shoulder adhesive capsulitis may help to alert clinicians for the diagnosis of unsuspected shoulder capsulitis.
To assess the association of shoulder adhesive capsulitis with cancer/therapy type and symptoms in cancer patients undergoing PET-CT.
Our prospective study received Institutional Review Board approval. Written informed consent was obtained from all patients, who answered a questionnaire regarding shoulder pain/stiffness at the time of PET-CT study, between March 2015 and April 2019. Patients with advanced glenohumeral arthrosis, metastatic disease or other mass in the shoulder, or shoulder arthroplasty were excluded. Patterns of shoulder capsule 18F-fluorodeoxyglucose (FDG) uptake were noted. Standard Uptake Value (SUV)max and SUVmean values were measured at rotator interval (RI) and deltoid muscle in bilateral shoulders. Normalized SUV (SUV of RI/SUV of deltoid muscle) was also calculated. We assessed if SUV values are different between symptomatic and asymptomatic patients in both shoulders. Covariates were age, gender, and therapy type (surgery, chemotherapy, radiation). Wilcoxon rank sum tests were used to compare unadjusted marginal differences for age, SUV measurements between symptomatic and asymptomatic patients. Multiple linear regression models were used to examine the relationship between right or left shoulder SUV measurements and symptom status, after adjusting for covariates. Statistical significance level was set at < 0.05.
Of 252 patients initially enrolled for the study (mean age 66 years, 67 symptomatic), shoulder PET-CT data were obtained in 200 patients (52 were excluded due to exclusion criteria above). The most common cancer types were lymphoma ( = 61), lung ( = 54) and breast ( = 53). No significant difference was noted between symptomatic and asymptomatic patients in terms of age, gender, proportion of patients who had surgical therapy and radiation therapy. A proportion of patients who received chemotherapy was higher in patients who were asymptomatic in the right shoulder compared to those symptomatic in the right shoulder (65% 48%, = 0.012). No such difference was seen for the left shoulder. In both shoulders, SUVmax and SUVmean were higher in symptomatic shoulders than asymptomatic shoulders (Left SUVmax 2.0 1.6, SUVmean 1.6 1.3, both < 0.002; Right SUVmax 2.2 1.8, SUVmean 1.8 1.5, both < 0.01). For lung cancer patients, bilateral RI SUVmax and SUVmean values were higher in symptomatic shoulders than asymptomatic shoulders. For other cancer patients, symptomatic patients had higher left RI SUVmax/mean than asymptomatic patients after adjustment.
In symptomatic patients metabolic activities in RI were higher than asymptomatic patients. Adhesive capsulitis should be considered in cancer patients with shoulder symptoms and positive FDG uptake in RI.
粘连性关节囊炎是一种相对常见的病症,可在癌症患者治疗期间发生。正电子发射断层扫描 - 计算机断层扫描(PET-CT)在癌症患者治疗后作为常规随访检查进行。了解PET-CT提示肩部粘连性关节囊炎的表现可能有助于提醒临床医生诊断未被怀疑的肩部关节囊炎。
评估接受PET-CT检查的癌症患者肩部粘连性关节囊炎与癌症/治疗类型及症状之间的关联。
我们的前瞻性研究获得了机构审查委员会的批准。在2015年3月至2019年4月期间,所有患者均签署了书面知情同意书,并在PET-CT检查时回答了有关肩部疼痛/僵硬的问卷。排除患有晚期盂肱关节病、转移性疾病或肩部其他肿块或肩部置换术的患者。记录肩部关节囊18F-氟脱氧葡萄糖(FDG)摄取模式。在双侧肩部的旋转间隙(RI)和三角肌处测量标准摄取值(SUV)最大值和SUV平均值。还计算了标准化SUV(RI的SUV/三角肌的SUV)。我们评估了有症状和无症状患者双肩的SUV值是否存在差异。协变量包括年龄、性别和治疗类型(手术、化疗、放疗)。采用Wilcoxon秩和检验比较有症状和无症状患者在年龄、SUV测量方面未经调整的边际差异。在调整协变量后,使用多元线性回归模型检验右肩或左肩SUV测量值与症状状态之间的关系。设定统计学显著性水平为<0.05。
最初纳入研究的252例患者(平均年龄66岁,67例有症状)中,200例患者获得了肩部PET-CT数据(52例因上述排除标准被排除)。最常见的癌症类型是淋巴瘤(=61)、肺癌(=54)和乳腺癌(=53)。有症状和无症状患者在年龄、性别、接受手术治疗和放射治疗的患者比例方面无显著差异。右肩无症状患者接受化疗的比例高于右肩有症状患者(65%对48%,=0.012)。左肩未见此类差异。在双肩中,有症状肩部的SUV最大值和SUV平均值均高于无症状肩部(左SUV最大值2.0对1.6,SUV平均值1.6对1.3,均<0.002;右SUV最大值2.2对1.8,SUV平均值1.8对1.5,均<0.01)。对于肺癌患者,有症状肩部的双侧RI SUV最大值和SUV平均值高于无症状肩部。对于其他癌症患者,调整后有症状患者的左RI SUV最大值/平均值高于无症状患者。
有症状患者RI处的代谢活性高于无症状患者。对于有肩部症状且RI处FDG摄取阳性的癌症患者,应考虑粘连性关节囊炎。